Why is Mono Pharmacare falling/rising?

As of 30-Jun, Mono Pharmacare Ltd's stock price is currently at 25.65, reflecting an increase of 1.15 or 4.69%. The stock has shown a positive performance today, outperforming its sector by 4%. However, despite this short-term gain, the stock has experienced a significant decline over the past month, with a return of -9.20%. Additionally, the stock's year-to-date performance is down by 25.97%, indicating a longer-term downward trend. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but remains below its 200-day moving average. Notably, there has been a drastic decline in investor participation, with delivery volume dropping by 89.8% against the 5-day average, which may signal reduced interest among investors.
In the broader market context, Mono Pharmacare's recent short-term return of +7.10% over the past week significantly outperformed the Sensex, which only gained 2.18% during the same period. However, the stock's longer-term performance remains concerning, as it has underperformed the benchmark over the past month, year-to-date, and year, with respective declines of -9.20%, -25.97%, and -36.51% compared to the Sensex's positive returns. This disparity suggests that while there may be some short-term recovery, the overall sentiment towards Mono Pharmacare remains negative, influenced by falling investor participation and a lack of positive factors to support a sustained upward movement.